Goal Date Confusion: The Downside Of Generic Drug Assessment Transparency
ANDA sponsors worry launch plans cannot be finalized if US FDA will not inform them whether their application requires a facility inspection.
ANDA sponsors worry launch plans cannot be finalized if US FDA will not inform them whether their application requires a facility inspection.